ArticleInfection and drug resistance2023

Efficacy and Safety of Longyizhengqi Granule in Treatment of Mild COVID-19 Patients Caused by SARS-CoV-2 Omicron Variant: A Prospective Study.

Miao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.